Fundraising Fox

Toro Neurovascular

Irvine, US · Founded 2021 · Delaware corporation

Toro Neurovascular develops endovascular stroke devices, including large-bore aspiration catheters featuring MicroFlex reinforcement-wire technology for treating ischemic stroke and large vessel occlusions. Its products are intended for physicians performing neurovascular thrombectomy procedures.

Founders & leadership

HPHyung Posalit
Hyung PosalitinCo-Founder & CEO
RWRyan Walker
Ryan WalkerinCo-Founder & COO
MPMarc Paris
Marc ParisChief Commercial Officer

Reported raises · per SEC filings

Form D private placements

$3M disclosed across 1 round · 2023

$3MraisedJul 2024 · 16 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Hyung PosalitExecutive Officer, Director
  • Ryan WalkerExecutive Officer
Offering amount
$3.5M
Amount sold
$3M
Minimum investment
$1
First sale
Mar 2023
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 4

by search overlap

Companies competing with Toro Neurovascular for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does Toro Neurovascular do?
Toro Neurovascular develops endovascular stroke devices, including large-bore aspiration catheters featuring MicroFlex reinforcement-wire technology for treating ischemic stroke and large vessel occlusions. Its products are intended for physicians performing neurovascular thrombectomy procedures.
How much funding has Toro Neurovascular raised?
Toro Neurovascular has disclosed $3M raised across 1 round.
Where is Toro Neurovascular headquartered?
Toro Neurovascular is headquartered in Irvine, US.